Studio City International Holdings Limited Announces Unaudited Third Quarter 2024 Earnings
05. November 2024 08:00 ET
|
Studio City
MACAU, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City International Holdings Limited Announces Unaudited First Quarter 2024 Earnings
30. April 2024 08:00 ET
|
Studio City
MACAU, April 30, 2024 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2023
22. März 2024 07:51 ET
|
Studio City
MACAU, March 22, 2024 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City International Holdings Limited Announces Filing of Annual Report on Form 20-F for Fiscal Year 2022
31. März 2023 08:43 ET
|
Studio City
MACAU, March 31, 2023 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City International Holdings Limited Announces Unaudited Fourth Quarter 2022 Earnings
01. März 2023 08:00 ET
|
Studio City
MACAU, March 01, 2023 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City Announces Earnings Release Date
04. Mai 2022 06:37 ET
|
Studio City
MACAU, May 04, 2022 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will release its...
Brooklyn ImmunoTherapeutics Completes Acquisition of Novellus Therapeutics
19. Juli 2021 08:00 ET
|
Brooklyn Immunotherapeutics LLC
Acquisition Advances Transformation Into Platform Company Focused on Cell, Gene Editing and Cytokine Therapy Company to hold Conference Call Today, July 19, 2021, at 4:15PM ET to Discuss the...